Patent details

EP2830596 Title: LIPID-DERIVED NEUTRAL NANOPARTICLES

Basic Information

Publication number:
EP2830596
PCT Application Number:
US2013034604
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137690053
PCT Publication Number:
WO2013149141
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIPID-DERIVED NEUTRAL NANOPARTICLES
French Title of Invention:
NANOPARTICULES NEUTRES DÉRIVÉES DE LIPIDES
German Title of Invention:
AUS LIPIDEN GEWONNENE NEUTRALE NANOPARTIKEL
SPC Number:

Dates

Filing date:
29/03/2013
Grant date:
30/12/2020
EP Publication Date:
04/02/2015
PCT Publication Date:
03/10/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/12/2020
EP B1 Publication Date:
30/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/03/2021
Expiration date:
29/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/12/2020
 
 

Name:
Translate Bio, Inc.
Address:
29 Hartwell Avenue, Lexington, MA 02421, United States (US)

Inventor

1

Name:
DEROSA, Frank
Address:
United States (US)

2

Name:
GUILD, Braydon, Charles
Address:
United States (US)

3

Name:
HEARTLEIN, Michael
Address:
United States (US)

Priority

Priority Number:
201261617478 P
Priority Date:
29/03/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/127; C12N 15/11; C12N 15/88; G01N 33/92;

Publication

European Patent Bulletin

1

Issue number:
202053
Publication date:
30/12/2020
Description:
Grant (B1)

2

Issue number:
202103
Publication date:
20/01/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages